Cited by 565Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

Kegeles, Lawrence S., Abi-Dargham, Anissa, Frankle, W. Gordon, Gil, Roberto, Cooper, Thomas B., Slifstein, Mark, Hwang, Dah-Ren, Huang, Yiyun, Haber, Suzanne N., Laruelle, Marc·2010·Archives of General Psychiatry

DOI 10.1001/archgenpsychiatry.2010.10

Open this paper in CoChat — free account

Abstract

CONTEXT: A long-standing version of the dopamine hypothesis of schizophrenia postulates that hyperactivity of dopaminergic transmission at D(2) receptors in the limbic striatum is associated with the illness and that blockade of mesolimbic D(2) receptors is responsible for the antipsychotic action of D(2) receptor antagonists. OBJECTIVE: To localize dopaminergic hyperactivity within the striatum in schizophrenia. DESIGN: Case-control study. SETTING: Inpatient research unit. PARTICIPANTS: Eighteen untreated patients with schizophrenia and 18 healthy control subjects matched for age, sex, ethnicity, parental socioeconomic status, cigarette smoking, and weight. MAIN OUTCOME MEASURES: Percentage change in dopamine D(2) receptor availability in striatal subregions within each subject measured by positron emission tomography with carbon 11-labeled raclopride before and during pharmacologically induced dopamine depletion. RESULTS: In the associative striatum, acute dopamine depletion resulted in a larger increase in D(2) receptor availability in patients with schizophrenia (mean [SD], 15% [7%]) than in control subjects (10% [7%], P = .045), suggesting higher synaptic dopamine concentration. Within the associative striatum, this effect was most pronounced in the precommissural dorsal caudate (15% [8%] in patients vs 9% [8%] in controls, P = .03). No between-group differences were observed in the limbic and sensorimotor striatum. CONCLUSIONS: These findings suggest that schizophrenia is associated with elevated dopamine function in associative regions of the striatum. Because the precommissural dorsal caudate processes information from the dorsolateral prefrontal cortex, this observation also suggests that elevated subcortical dopamine function might adversely affect performance of the dorsolateral prefrontal cortex in schizophrenia. On the other hand, the absence of a group difference in the limbic striatum brings into question the therapeutic relevance of the mesolimbic selectivity of second-generation antipsychotic drugs.

Integrity signals

Registry

Crossref · 10.1001/archgenpsychiatry.2010.10

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Four Factor Index of Social Status
Paschou, R. (1975) · Cited by 6,989
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Four Factor Index of Social Status [1975]
Hollingshead, A. B. (1975) · Cited by 5,151
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161
Dopamine in schizophrenia: a review and reconceptualization
Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,051
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008

Show all 89 references

Sorted by citations

Items 301–400 of 565

Cerebral blood flow in striatal regions is associated with apathy in patients with schizophrenia
Schneider, K., Michels, L., Hartmann-Riemer, M. N., Burrer, A., Tobler, P. N., Stämpfli, P., Kirschner, M., Seifritz, E., & Kaiser, S. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170150 · Cited by 17
Association between functional and structural connectivity of the corticostriatal network in people with schizophrenia and unaffected first-degree relatives
Li, P., Jing, R., Zhao, R., Shi, L., Sun, H., Ding, Z., Lin, X., Lü, L., & Yong Fan, A. (2020) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.190015 · Cited by 17
Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study
Girgis, R. R., Slifstein, M., Brucato, G., Kegeles, L. S., Colibazzi, T., Lieberman, J. A., & Abi‐Dargham, A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00934-w · Cited by 17
Self-citation
Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET Imaging
Iliopoulou, S. M., Tsartsalis, S., Kaiser, S., Millet, P., & Tournier, B. B. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s334027 · Cited by 17
Dopamine, Psychosis, and Symptom Fluctuation: A Narrative Review
Novak, G., & Seeman, M. (2022) · Healthcare · doi:10.3390/healthcare10091713 · Cited by 17
Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment
Ward, H. B., Nemeroff, C. B., Carpenter, L. L., Grzenda, A. L., McDonald, W. M., Rodríguez, C. I., & Kraguljac, N. V. (2023) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2023.100106 · Cited by 20
Receptor screening technologies in the evaluation of Amazonian ethnomedicines with potential applications to cognitive deficits
McKenna, D. J., Ruiz, J. M., Hoye, T. R., Roth, B. L., & Shoemaker, A. T. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.12.037 · Cited by 15
Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia
Balla, A., Schneider, S., Sershen, H. W., & Javitt, D. C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.03.006 · Cited by 16
Copy number deletion burden is associated with cognitive, structural, and resting-state network differences in patients with schizophrenia
Martin, A. K., Robinson, G. A., Reutens, D. C., & Mowry, B. J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.002 · Cited by 16
Estimating the effect of endogenous dopamine on baseline [11C]‐(+)‐PHNO binding in the human brain
Caravaggio, F., Kegeles, L. S., Wilson, A., Remington, G., Borlido, C., Mamo, D., & Graff-Guerrero, A. (2016) · Synapse · doi:10.1002/syn.21920 · Cited by 16
Self-citation
Antipsychotic and anticholinergic drugs
Meltzer, H. Y., & Bobo, W. V. (2020) · doi:10.1093/med/9780198713005.003.0064 · Cited by 16
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study
Fervaha, G., Caravaggio, F., Mamo, D. C., Mulsant, B. H., Pollock, B. G., Nakajima, S., Gerretsen, P., Rajji, T. K., Mar, W., Iwata, Y., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4415-6 · Cited by 16
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study
Plitman, E., Chavez, S., Nakajima, S., Iwata, Y., Chung, J. K., Caravaggio, F., Kim, J. N., Alshehri, Y., Chakravarty, M. M., Luca, V. D., et al. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.01.004 · Cited by 16
Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia
Slifstein, M., & Abi‐Dargham, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.015 · Cited by 16
Self-citation
Accumulation of Carbonyl Proteins in the Brain of Mouse Model for Methylglyoxal Detoxification Deficits
Koike, S., Toriumi, K., Kasahara, S., Kibune, Y., Ishida, Y.-I., Dan, T., Miyata, T., Arai, M., & Ogasawara, Y. (2021) · Antioxidants · doi:10.3390/antiox10040574 · Cited by 16
Temporal-spatial dynamic functional connectivity analysis in schizophrenia classification
Pan, C., Yu, H., Fei, X., Zheng, X., & Yu, R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.965937 · Cited by 18
Relation between Dopamine Synthesis Capacity and Cell-Level Structure in Human Striatum: A Multi-Modal Study with Positron Emission Tomography and Diffusion Tensor Imaging
Kawaguchi, H., Obata, T., Takano, H., Nogami, T., Suhara, T., & Ito, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087886 · Cited by 16
Ameliorative effect of yokukansan on vacuous chewing movement in haloperidol-induced rat tardive dyskinesia model and involvement of glutamatergic system
Sekiguchi, K., Kanno, H., Yamaguchi, T., Ikarashi, Y., & Kase, Y. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.08.008 · Cited by 16
Aberrant functioning of the putamen links delusions, antipsychotic drug dose, and compromised connectivity in first episode psychosis—Preliminary fMRI findings
Raij, T. T., Mäntylä, T. J. S., Kieseppä, T., & Suvisaari, J. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.06.008 · Cited by 15
Biological Psychiatry and Psychopharmacology
Fountoulakis, K. N., Nimatoudis, I., & Stahl, S. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-18323-3_13 · Cited by 17
Antipsychotics and the Dopamine–Serotonin Connection
Ellenbroek, B. A., & Cesura, A. M. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_51 · Cited by 16
Elevated striatal dopamine function in immigrants and their children: a risk mechanism for psychosis
Mizrahi, R. (2016) · Intrinsic Activity · doi:10.25006/ia.4.s2-a16.2 · Cited by 16
Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia.
Caravaggio, F., Hahn, M., Nakajima, S., Gerretsen, P., Remington, G., & Graff-Guerrero, A. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.06.011 · Cited by 17
Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: A tensor‐based morphometry study
Yang, Y., Nuechterlein, K. H., Phillips, O. R., Gutman, B. A., Kurth, F., Dinov, I. D., Thompson, P. M., Asarnow, R. F., Toga, A. W., & Narr, K. L. (2011) · Human Brain Mapping · doi:10.1002/hbm.21349 · Cited by 15
New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain
Shumay, E., Wiers, C. E., Kojori, E. S., Kim, S. W., Hodgkinson, C. A., Sun, H., Tomasi, D. G., Wong, C., Weinberger, D. R., Wang, G., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3155-16.2017 · Cited by 15
The relationship between subcortical brain volume and striatal dopamine D2/3receptor availability in healthy humans assessed with [11C]‐raclopride and [11C]‐(+)‐PHNO PET
Caravaggio, F., Chung, J. K., Plitman, E., Boileau, I., Gerretsen, P., Kim, J., Iwata, Y., Patel, R., Chakravarty, M. M., Remington, G. J., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23744 · Cited by 15
Striatal transcriptome changes linked to drug‐induced repetitive behaviors
Crittenden, J. R., Gipson, T. A., Smith, A. C., Bowden, H. A., Yildirim, F., Fischer, K. B., Yim, M., Housman, D. E., & Graybiel, A. M. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15116 · Cited by 13
Standardized Data Acquisition for Neuromelanin-sensitive Magnetic Resonance Imaging of the Substantia Nigra
Salzman, G., Kim, J., Horga, G., & Wengler, K. (2021) · Journal of Visualized Experiments · doi:10.3791/62493 · Cited by 18
Lipopeptide Pepducins as Therapeutic Agents
Michael, E., Covic, L., & Kuliopulos, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1752-6_21 · Cited by 15
Update on current animal models for schizophrenia: are they still useful?
Uliana, D., Gomes, F. V., & Grace, A. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000854 · Cited by 11
Psychotic like experiences as part of a continuum of psychosis: Associations with effort-based decision-making and reward responsivity
Ermel, J. A., Moran, E. K., Culbreth, A. J., & Barch, D. M. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.026 · Cited by 18
Continuous-flow synthesis of [11C]raclopride, a positron emission tomography radiotracer, on a microfluidic chip
Haroun, S., Sanei, Z., Jivan, S., Schaffer, P. C., Ruth, T. J., & Li, P. C. H. (2013) · Canadian Journal of Chemistry · doi:10.1139/cjc-2012-0331 · Cited by 15
No effect of dopamine depletion on the binding of the high-affinity D2/3 radiotracer [11C]FLB 457 in the human cortex
Frankle, W. G., Mason, N. S., Rabiner, E. A., Ridler, K., May, M. A., Asmonga, D., Chen, C., Kendro, S., Cooper, T. B., Mathis, C. A., et al. (2010) · Synapse · doi:10.1002/syn.20806 · Cited by 15
Self-citation
Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia
Slifstein, M., Qü, W., Gil, R. B., Weinstein, J. J., Perlman, G., Jaworski-Calara, T., Meng, J., Hu, B., Moeller, S. J., Horga, G., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01975-3 · Cited by 14
Self-citation
Reward Processing in Mood Disorders and Schizophrenia: A Neurodevelopmental Framework
Nusslock, R., Mittal, V. A., & Alloy, L. B. (2025) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-080822-041621 · Cited by 16
Fronto-striato-thalamic circuit connectivity and neuromelanin in schizophrenia: an fMRI and neuromelanin-MRI study
Choi, S., Kim, M., Kim, T., Choi, E., Lee, J., Moon, S., Cho, S. S., Lee, J., & Kwon, J. S. (2023) · Schizophrenia · doi:10.1038/s41537-023-00410-8 · Cited by 14
Amotivation is associated with smaller ventral striatum volumes in elderly patients with schizophrenia
Caravaggio, F., Fervaha, G., Iwata, Y., Plitman, E., Chung, J., Nakajima, S., Mar, W., Gerretsen, P., Kim, J., Chakravarty, M., et al. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4818 · Cited by 13
Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study
Persson, J., Szalisznyó, K., Antoni, G., Wall, A., Fällmar, D., Zora, H., & Bodén, R. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01021-0 · Cited by 13
The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia
Kaar, S. J., Angelescu, I., Nour, M. M., Marques, T. R., Sharman, A., Sajjala, A., Hutchison, J. B., McGuire, P. K., Large, C. H., & Howes, O. D. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06216-3 · Cited by 14
Different relationships between central dopamine system and sub-processes of inhibition: Spontaneous eye blink rate relates with N2 but not P3 in a Go/Nogo task
Zhang, T., Wang, C., Tan, F., Mou, D., Zheng, L., & Chen, A. (2016) · Brain and Cognition · doi:10.1016/j.bandc.2016.04.003 · Cited by 14
Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System
Santis, M. D., Lian, J., Huang, X., & Deng, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111944 · Cited by 15
Secretome of Differentiated PC12 Cells Enhances Neuronal Differentiation in Human Mesenchymal Stem Cells Via NGF-Like Mechanism
Srivastava, A., Singh, S., Pandey, A., Kumar, D., Rajpurohit, C. S., Khanna, V. K., & Pant, A. B. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0981-4 · Cited by 14
Multilocus genetic profile in dopaminergic pathway modulates the striatum and working memory
Wang, C., Liu, B., Zhang, X., Cui, Y. J., Yu, C., & Jiang, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-23191-y · Cited by 14
Imaging as Tool to Investigate Psychoses and Antipsychotics
Booij, J., & van Amelsvoort, T. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_12 · Cited by 14
Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials
Rao, N. P., & Remington, G. J. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.795945 · Cited by 13
Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
Zhang, Y., Peng, Y., Song, Y., Zhou, Y., Zhang, S., Yang, G., Yang, Y., Li, W., Yue, W., Lv, L., et al. (2022) · Brain and Behavior · doi:10.1002/brb3.2535 · Cited by 13
Dorsal striatal hypoconnectivity predicts antipsychotic medication treatment response in first‐episode psychosis and unmedicated patients with schizophrenia
Nelson, E. A., Kraguljac, N. V., Maximo, J. O., Armstrong, W. P., & Lahti, A. C. (2022) · Brain and Behavior · doi:10.1002/brb3.2625 · Cited by 13
QSAR-CoMSIA applied to antipsychotic drugs with their dopamine D2 and serotonine 5HT2A membrane receptors
Avram, S., Duda-Seiman, D., Borcan, F., & Wolschann, P. (2011) · Journal of the Serbian Chemical Society · doi:10.2298/jsc100806022a · Cited by 13
Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors
Santis, M. D., Huang, X., & Deng, C. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s158545 · Cited by 12
Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery
Kos, M. Z., Duan, J., Sanders, A. R., Blondell, L., Drigalenko, E. I., Carless, M. A., Gejman, P. V., Göring, H. H. H., MGS, Gejman, P. V., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0325-1 · Cited by 13
Quantification of receptor–ligand binding potential in sub-striatal domains using probabilistic and template regions of interest
del Campo, N., Tait, R. J., Acosta‐Cabronero, J., Hong, Y. T., Izquierdo‐Garcia, D., Smith, R., Aigbirhio, F. I., Sahakian, B. J., Müller, U., Robbins, T. W., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.071 · Cited by 12
Neurodegenerative Aspects in Vulnerability to Schizophrenia Spectrum Disorders
Archer, T., Ricci, S., Garcia, D., & Ricciardi, M. R. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9473-0 · Cited by 14
Exploring the relationship between social attachment and dopamine D2/3receptor availability in the brains of healthy humans using [11C]-(+)-PHNO
Caravaggio, F., Chung, J. K., Gerretsen, P., Fervaha, G., Nakajima, S., Plitman, E., Iwata, Y., Wilson, A. A., & Graff‐Guerrero, A. (2016) · Social Neuroscience · doi:10.1080/17470919.2016.1152997 · Cited by 12
Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome
van Duin, E. D. A., Kasanova, Z., Hernaus, D., Ceccarini, J., Heinzel, A., Mottaghy, F. M., Shali, S. M., Winz, O., Frank, M. J., Beck, M. C. H., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.005 · Cited by 12
Amphetamine-induced striatal dopamine release in schizotypal personality disorder
Thompson, J. L., Rosell, D., Slifstein, M., Xu, X., Rothstein, E., Modiano, Y. A., Kegeles, L., Koenigsberg, H., New, A., Hazlett, E., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05561-5 · Cited by 10
Self-citation
The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients
Shin, S. H., Jung, W. H., McCutcheon, R. A., Veronese, M., Beck, K., Lee, J., Lee, Y., Howes, O. D., Kim, E., & Kwon, J. S. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0033 · Cited by 12
Effects of Dopamine on Sensitivity to Social Bias in Parkinson's Disease
Djamshidian, A., O’Sullivan, S. S., Lees, A. J., & Averbeck, B. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032889 · Cited by 12
Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.
Caravaggio, F., Gerretsen, P., Mar, W., Chung, J., Plitman, E., Nakajima, S., Kim, J., Iwata, Y., Patel, R., Chakravarty, M., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.03.020 · Cited by 12
The neural correlates of apathy in schizophrenia: An exploratory investigation
Caravaggio, F., Fervaha, G., Menon, M., Remington, G., Graff-Guerrero, A., & Gerretsen, P. (2017) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.10.027 · Cited by 11
The SNAP25 Interactome in Ventromedial Caudate in Schizophrenia Includes the Mitochondrial Protein ARF1
Ramos‐Miguel, A., Barakauskas, V., Alamri, J., Miyauchi, M., Barr, A. M., Beasley, C. L., Rosoklija, G. B., Mann, J. J., Dwork, A. J., Moradian, A., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.12.045 · Cited by 12
Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia
Moran, L. V., Stoeckel, L. E., Wang, K., Caine, C. E., Villafuerte, R. A., Calderon, V., Baker, J. T., Öngür, D., Janes, A. C., Evins, A. E., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4794-3 · Cited by 13
Medial septum activation produces opposite effects on dopamine neuron activity in the ventral tegmental area and substantia nigra in MAM vs. normal rats
Bortz, D. M., & Grace, A. A. (2018) · Schizophrenia · doi:10.1038/s41537-018-0059-3 · Cited by 12
Omega-3 fatty acids in cause, prevention and management of violence in schizophrenia: Conceptualization and application
Ouyang, W., Sun, G., & Hsu, M. (2019) · Aggression and Violent Behavior · doi:10.1016/j.avb.2019.101347 · Cited by 12
Striosomes Target Nigral Dopamine-Containing Neurons via Direct-D1 and Indirect-D2 Pathways Paralleling Classic Direct-Indirect Basal Ganglia SystemsPreprint
Lazaridis, I., Crittenden, J. R., Ahn, G., Hirokane, K., Yoshida, T., Wickersham, I. R., Mahar, A., Skara, V., Loftus, J. H., Parvataneni, K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.01.596922 · Cited by 12
Functional dissociation of behavioral effects from acetylcholine and glutamate released from cholinergic striatal interneurons
Kljakic, O., Janíčková, H., Skirzewski, M., Reichelt, A., Memar, S., Mestikawy, S. E., Li, Y., Saksida, L. M., Bussey, T. J., Prado, V. F., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101425r · Cited by 11
The organization of frontostriatal brain wiring in non-affective early psychosis compared with healthy subjects using a novel diffusion imaging fiber cluster analysis
Levitt, J. J., Zhang, F., Vangel, M. G., Nestor, P. G., Yogesh Rathi, A., Karayumak, S. C., Kubicki, M. R., Coleman, M., Lewandowski, K. E., Holt, D. J., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02031-0 · Cited by 11
Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [18F]-VAT
Weinstein, J. J., Moeller, S. J., Perlman, G., Gil, R. B., Snellenberg, J. X. V., Wengler, K., Meng, J., Slifstein, M., & Abi‐Dargham, A. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.01.019 · Cited by 11
Self-citation
Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients
Sivaraman, S., Kraguljac, N. V., White, D. M., Morgan, C. J., Gonzales, S. S., & Lahti, A. C. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.06.003 · Cited by 11
Associations of neural processing of reward with posttraumatic stress disorder and secondary psychotic symptoms in trauma-affected refugees
Uldall, S. W., Nielsen, M. Ø., Carlsson, J. M., Glenthoj, B. Y., Siebner, H. R., Madsen, K. H., Madsen, C. G., Leffers, A.-M., Nejad, A. B., & Rostrup, E. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1730091 · Cited by 11
A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia
Lum, J. S., Millard, S. J., Huang, X., Ooi, L., & Newell, K. A. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170077 · Cited by 11
Setting the beat of an internal clock: Effects of dexamphetamine on different interval ranges of temporal processing in healthy volunteers
Graham‐Schmidt, K. T., Martin‐Iverson, M. T., & Waters, F. A. V. (2019) · PsyCh Journal · doi:10.1002/pchj.274 · Cited by 11
Is contrast sensitivity a physiological marker in attention-deficit hyperactivity disorder?
Dönmez, Y. E., Özcan, Ö., Çankaya, C., Berker, M., ULUCAN, P. B., Güntürkün, P. N., & Ceylan, O. M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110326 · Cited by 12
Systematic review and meta-analysis on the effects of chronic peri-adolescent cannabinoid exposure on schizophrenia-like behaviour in rodents
Li, Z., Mukherjee, D., Duric, B., Austin-Zimmerman, I., Trotta, G., Spinazzola, E., Quattrone, D., Murray, R. M., & Forti, M. D. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02668-5 · Cited by 10
How have developments in molecular imaging techniques furthered schizophrenia research?
Thompson, J. L., Urban, N., & Abi‐Dargham, A. (2009) · Imaging in Medicine · doi:10.2217/iim.09.22 · Cited by 9
Self-citation
Abnormal interhemispheric functional cooperation in schizophrenia follows the neurotransmitter profiles
He, K., Hua, Q., Li, Q., Zhang, Y., Yao, X., Yang, Y., Xu, W., Sun, J., Wang, L., Wang, A., et al. (2023) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.230037 · Cited by 10
Baseline putamen volume as a predictor of positive symptom reduction in patients at clinical high risk for psychosis: A preliminary study
Hong, S. B., Lee, T. Y., Kwak, Y. B., Kim, S. N., & Kwon, J. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.029 · Cited by 10
Tyrosine hydroxylase localization in the nucleus accumbens in schizophrenia
McCollum, L. A., McCullumsmith, R. E., & Roberts, R. C. (2016) · Brain Structure and Function · doi:10.1007/s00429-015-1174-9 · Cited by 11
Schizophrenia: Recent Advances in LC–MS/MS Methods to Determine Antipsychotic Drugs in Biological Samples
Queiroz, M. E. C., Pinto, M. A. L., Cruz, J. C., Ushirohira, J. M., Dias, I. C. D. S., & Hallak, J. E. C. (2019) · Bioanalysis · doi:10.4155/bio-2018-0155 · Cited by 10
Clinical Aspects of Comorbid Schizophrenia and Idiopathic Parkinson’s Disease
de Jong, M. H., Zemel, D., & Gool, A. R. V. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.deze.012513 · Cited by 10
Postnatal Neurogenesis and Dopamine Alterations in Early Psychosis
Inta, D., Lima‐Ojeda, J. M., Gass, P., & Fusar‐Poli, P. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803251998 · Cited by 10
The Striatum and Dopamine
Horga, G., & Abi‐Dargham, A. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.191 · Cited by 10
Self-citation
The effects of acute dopamine depletion on resting-state functional connectivity in healthy humans
Caravaggio, F., Barnett, A. J., Nakajima, S., Iwata, Y., Kim, J., Borlido, C., Mar, W., Gerretsen, P., Remington, G. J., & Graff‐Guerrero, A. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.01.003 · Cited by 10
NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia
Dwyer, G. E., Johnsen, E., & Hugdahl, K. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.025 · Cited by 9
The Mechanisms of Persisting Disability in Schizophrenia: Imprecise Predictive Coding via Corticostriatothalamic-Cortical Loop Dysfunction
Liddle, P. F., & Sami, M. B. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.08.007 · Cited by 9
Resolving the heterogeneity of dopamine subsystems dysfunction in schizophrenia: a PET meta-analysis
Zhao, Z. W., Li, X., Xie, Y., Lin, L., Wei, L., Chang, Z., Luo, Y., Dong, H., Zhang, X., Dong, Q., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00684-0 · Cited by 11
Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia
Vinnakota, C., Hudson, M. R., Jones, N. C., Sundram, S., & Hill, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411835 · Cited by 7
Deep learning-based image analysis identifies a DAT-negative subpopulation of dopaminergic neurons in the lateral Substantia nigra
Burkert, N., Roy, S., Häusler, M., Wuttke, D., Müller, S., Wiemer, J., Hollmann, H., Oldrati, M., Ramírez‐Franco, J., Benkert, J., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05441-6 · Cited by 11
The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions
Abbs, B., Achalia, R. M., Adelufosi, A. O., Aktener, A. Y., Beveridge, N. J., Bhakta, S. G., Blackman, R. K., Bora, E., Byun, M. S., Cabanis, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.024 · Cited by 8
Altered Expression of a Unique Set of Genes Reveals Complex Etiology of Schizophrenia
Kumar, A., Singh, H. N., Pareek, V., Raza, K., Pavan, K., Faiq, M. A., Mochan, S., Dantham, S., & Upadhyaya, A. D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00906 · Cited by 10
Calculating Occupancy when One does not have Baseline: A Comparison of Different Options
Kim, E., Howes, O. D., Yu, K., Jeong, J. M., Lee, J. S., Jang, I., Shin, S., Kapur, S., & Kwon, J. S. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.54 · Cited by 9
Drug information update. Unconventional treatment strategies for schizophrenia: Polypharmacy and heroic dosing
Moore, B. A., Morrissette, D. A., Meyer, J. M., & Stahl, S. M. (2017) · BJPsych Bulletin · doi:10.1192/pb.bp.115.053223 · Cited by 9
Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis
Vingerhoets, C., Bloemen, O., Boot, E., Bakker, G., de Koning, M. B., Alves, F. D. S., Booij, J., & van Amelsvoort, T. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.11.014 · Cited by 9
Schizophrenia-associated changes in neuronal subpopulations in the human midbrain
Alsema, A. M., Puvogel, S., Kracht, L., Webster, M. J., Weickert, C. S., Eggen, B. J. L., & Sommer, I. E. (2024) · Brain · doi:10.1093/brain/awae321 · Cited by 8
Functional brain substrate of quality of life in patients with schizophrenia: A brain SPECT multidimensional analysis
Faget, C., Boyer, L., Richieri, R. M., Auquier, P., Lançon, C., & Guedj, É. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.02.005 · Cited by 9
Structural Brain Network Abnormalities in Parkinson’s Disease With Freezing of Gait
Jin, C., Yang, L., Qi, S., Teng, Y., Li, C., Yao, Y., Ruan, X., & Wei, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.944925 · Cited by 8
Cross-species striatal hubs: Linking anatomy to resting-state connectivity
Peng, X., Trambaiolli, L. R., Choi, E. Y., Lehman, J. F., Linn, G. S., Russ, B. E., Schroeder, C. E., Haber, S. N., & Liu, H. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120866 · Cited by 7
Self-citation
Personalized psychiatry with human iPSCs and neuronal reprogramming
Bardy, C., Greenberg, Z., Perry, S. W., & Licinio, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00012-2 · Cited by 9
A Real-World Observation of Antipsychotic Effects on Brain Volumes and Intrinsic Brain Activity in Schizophrenia
Chen, Y., Womer, F. Y., Feng, R., Zhang, X., Zhang, Y., Duan, J., Chang, M., Yin, Z., Jiang, X., Wei, S., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.749316 · Cited by 8
Dopaminergic responses in the core part of the nucleus accumbens to subcutaneous MK801 administration are increased following postnatal transient blockade of the prefrontal cortex
Tagliabue, E., Pouvreau, T., Eybrard, S., Meyer, F., & Louilot, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.021 · Cited by 8
Applications of innovative technologies to the delivery of antipsychotics
Bergonzi, M. C., Bilia, A. R., & Landucci, E. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.019 · Cited by 8

Authors: Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M.
Affiliations: Columbia University Irving Medical Center (US)
ORCID: Kegeles, Lawrence S.
Frankle, W. Gordon
Cooper, Thomas B.
Slifstein, Mark
Huang, Yiyun
Haber, Suzanne N.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 2010-03-01
Volume: 67
Issue: 3
Pages: 231
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archgenpsychiatry.2010.10
OpenAlex: W1999984108
Cited by: 565
References: 89
Citations by year: 2026: 17 · 2025: 26 · 2024: 33 · 2023: 25 · 2022: 42 · 2021: 23 · 2020: 32 · 2019: 42 · 2018: 32 · 2017: 38 · 2016: 45 · 2015: 41 · 2014: 47 · 2013: 32 · 2012: 47
FWCI: 25.78
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (K02MH01603-01, K02MH001603, R01MH054192)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: schizophrenia, synaptic dopamine, associative striatum, dorsal caudate, dopamine depletion, mesolimbic dopamine system, dopamine hypothesis of schizophrenia, atypical antipsychotics, dorsolateral prefrontal cortex, positron emission tomography, raclopride
MeSH terms: Adult, Brain Mapping, Carbon Radioisotopes, Caudate Nucleus, Corpus Striatum, Dopamine, Female, Humans, Image Processing, Computer-Assisted, Male, Synaptic Transmission, Putamen, Schizophrenia, Synapses, Case-Control Studies, Prefrontal Cortex, Receptors, Dopamine D2, alpha-Methyltyrosine, Raclopride, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks